Severe skin infections
暂无分享,去创建一个
[1] O. Chosidow,et al. Clindamycin resistance in Group A streptococcal infections: A single‐centre retrospective cohort study of 186 patients , 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.
[2] D. Annane,et al. Healthcare trajectory of critically ill patients with necrotizing soft tissue infections: a multicenter retrospective cohort study using the clinical data warehouse of Greater Paris University Hospitals , 2022, Annals of Intensive Care.
[3] O. Chosidow,et al. Necrotising soft-tissue infections. , 2022, The Lancet. Infectious diseases.
[4] Nicolás W Cortés-Penfield,et al. Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate. , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] J. Rigdon,et al. Duration of Antibiotic Therapy in Necrotizing Soft Tissue Infections: Shorter is Safe. , 2022, Surgical infections.
[6] E. Sbidian,et al. From the Cochrane Library: Interventions for Necrotizing Soft Tissue Infections in Adults , 2021, JMIR Dermatology.
[7] Dennis Y Kim,et al. Short Courses of Antibiotics Are Safe in Necrotizing Soft Tissue Infections , 2021, The American surgeon.
[8] O. Chosidow,et al. Antibiotics in Necrotizing Soft Tissue Infections , 2021, Antibiotics.
[9] A. Luciani,et al. Long-term quality of life in necrotizing soft-tissue infection survivors: a monocentric prospective cohort study , 2021, Annals of Intensive Care.
[10] W. Schaffner,et al. Patterns of antibiotic nonsusceptibility among invasive group A Streptococcus infections-United States, 2006-2017. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] S. Valdezate,et al. Invasive Streptococcus pyogenes disease in Spain: a microbiological and epidemiological study covering the period 2007–2019 , 2021, European Journal of Clinical Microbiology & Infectious Diseases.
[12] M. Thy,et al. Dynamic Changes in Microbial Composition During Necrotizing Soft-Tissue Infections in ICU Patients , 2021, Frontiers in Medicine.
[13] Sameer S. Kadri,et al. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. , 2020, The Lancet. Infectious diseases.
[14] E. Bulger,et al. Outcomes of β-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] M. Madsen,et al. Incidence, comorbidity and mortality in patients with necrotising soft-tissue infections, 2005–2018: a Danish nationwide register-based cohort study , 2020, BMJ Open.
[16] Michael W. Spiller,et al. Invasive Group A Streptococcal Infections Among People Who Inject Drugs and People Experiencing Homelessness in the United States, 2010-2017. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] M. Madsen,et al. Understanding necrotizing soft tissue infections in the intensive care unit , 2020, Intensive Care Medicine.
[18] C. Woodman,et al. A 16-year Longitudinal Cohort Study of Incidence and Bacteriology of Necrotising Fasciitis in England , 2020, World Journal of Surgery.
[19] M. Good. Streptococcus: An organism causing diseases beyond neglect , 2020, PLoS neglected tropical diseases.
[20] P. Wolkenstein,et al. Health‐related quality of life and long‐term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients , 2020, The British journal of dermatology.
[21] Yao-Hung Hubert Tsai,et al. Predictors for gram-negative monomicrobial necrotizing fasciitis in southern Taiwan , 2020, BMC infectious diseases.
[22] V. M. D. Martins dos Santos,et al. Risk Factors and Predictors of Mortality in Streptococcal Necrotizing Soft-tissue Infections: A Multicenter Prospective Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] E. Han,et al. The incidence and seasonal variation of necrotizing fasciitis in Korea: a nationwide cross-sectional study. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[24] L. Leenen,et al. Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis , 2020, World Journal of Emergency Surgery.
[25] O. Chosidow,et al. Early identification of patients at high risk of group A streptococcus-associated necrotizing skin and soft tissue infections: a retrospective cohort study , 2019, Critical Care.
[26] E. Sbidian,et al. Impact of a multidisciplinary care bundle for necrotizing skin and soft tissue infections: a retrospective cohort study , 2019, Annals of Intensive Care.
[27] T. Nedrebø,et al. Molecular profiling of tissue biopsies reveals unique signatures associated with streptococcal necrotizing soft tissue infections , 2019, Nature Communications.
[28] V. M. D. Martins dos Santos,et al. Patient’s characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study , 2019, Intensive Care Medicine.
[29] O. Chiara,et al. Intensive multidisciplinary management in critical care patients affected by severe necrotizing soft tissue infections: a cooperative method to improve the efficacy of treatment , 2019, European Journal of Clinical Microbiology & Infectious Diseases.
[30] W. Graninger,et al. S2k guidelines for skin and soft tissue infections Excerpts from the S2k guidelines for “calculated initial parenteral treatment of bacterial infections in adults – update 2018“ , 2019, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[31] Dennis Y Kim,et al. Chance to cut: defining a negative exploration rate in patients with suspected necrotizing soft tissue infection , 2019, Trauma Surgery & Acute Care Open.
[32] M. Boermeester,et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections , 2018, World Journal of Emergency Surgery.
[33] L. Valiquette,et al. Secular trends in incidence of invasive beta-hemolytic streptococci and efficacy of adjunctive therapy in Quebec, Canada, 1996-2016 , 2018, PloS one.
[34] S. Jaber,et al. Long-term quality of life in adult patients surviving purpura fulminans: an exposed-unexposed multicenter cohort study. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] S. Logsetty,et al. Factors predicting health-related quality of life following necrotizing fasciitis. , 2018, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[36] T. Parks,et al. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis , 2018, Clinical Infectious Diseases.
[37] D. Stevens,et al. Necrotizing Soft-Tissue Infections. , 2017, The New England journal of medicine.
[38] S. Choi,et al. Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection , 2017, Infection & chemotherapy.
[39] Charles Warner-Hillard,et al. Effect of transfer status on outcomes for necrotizing soft tissue infections. , 2017, The Journal of surgical research.
[40] E. Sbidian,et al. Mortality of necrotizing fasciitis: relative influence of individual and hospital‐level factors, a nationwide multilevel study, France, 2007–12 , 2017, The British journal of dermatology.
[41] T. Lange,et al. Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial , 2017, Intensive Care Medicine.
[42] Sameer S. Kadri,et al. Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score–Matched Analysis From 130 US Hospitals , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] Derek Yang,et al. A Multi-Center Review of Care Patterns and Outcomes in Necrotizing Soft Tissue Infections. , 2016, Surgical infections.
[44] F. Andreoni,et al. Clindamycin Affects Group A Streptococcus Virulence Factors and Improves Clinical Outcome , 2016, The Journal of infectious diseases.
[45] A. Rahmouni,et al. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study. , 2015, Journal of the American Academy of Dermatology.
[46] C. Vinnard,et al. Deaths from necrotizing fasciitis in the United States, 2003–2013 , 2015, Epidemiology and Infection.
[47] R. Amathieu,et al. Management of necrotizing soft tissue infections in the intensive care unit: results of an international survey , 2015, Intensive Care Medicine.
[48] K. McBride,et al. Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study , 2015, BMC Infectious Diseases.
[49] A. Norrby-Teglund,et al. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[50] J. Carapetis,et al. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] Chin-Ho Wong,et al. Early diagnosis of necrotizing fasciitis , 2014, The British journal of surgery.
[52] D. Seehofer,et al. Treatment, outcome and quality of life after Fournier's gangrene: a multicentre study , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[53] F. Rivara,et al. Necrotizing Soft-Tissue Infections: Differences in Patients Treated at Burn Centers and Non-Burn Centers , 2008, Journal of burn care & research : official publication of the American Burn Association.
[54] Chin-Ho Wong,et al. Approach to debridement in necrotizing fasciitis. , 2008, American journal of surgery.
[55] Patchen Dellinger,et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[56] P. Leaverton,et al. Invasive Group A Streptococcal Infections in Florida , 2003, Southern medical journal.
[57] A. Norrby-Teglund,et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] L. Schouls,et al. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. , 2001, International journal of antimicrobial agents.
[59] R. Kaul,et al. Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome—A Comparative Observational Study , 1999 .
[60] R. Kaul,et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. , 1997, The American journal of medicine.
[61] I. Brook,et al. Clinical and microbiological features of necrotizing fasciitis , 1995, Journal of clinical microbiology.
[62] V. Winn,et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. , 1988, The Journal of infectious diseases.
[63] H. Tai,et al. Predisposing factors of necrotizing fasciitis with comparison to cellulitis in Taiwan: A nationwide population-based case-control study. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.